SCHEMBL2432247

SCHEMBL2432247

CC(CNC(N)=O)c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ BCAT2 O15382 1/20 0.66
▸ AOC3 Q16853 1/20 0.58
▸ NPC1 O15118 1/20 0.58
▸ RAB9A P51151 1/20 0.58
▸ TAAR1 Q96RJ0 4/20 0.54
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ TP53 P04637 2/20 0.48
▸ NR3C2 P08235 1/20 0.47
▸ APAF1 O14727 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ BCL2 P10415 4/20 0.45
▸ BCL2L1 Q07817 4/20 0.45
▸ MCL1 Q07820 4/20 0.45
▸ BCL2A1 Q16548 4/20 0.45
▸ BAK1 Q16611 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2328840 0.86 NPC1 (0.55) BCAT2AOC3NPC1RAB9ATAAR1
SCHEMBL2328836 0.86 NPC1 (0.55) BCAT2AOC3NPC1RAB9ATAAR1
SCHEMBL4530460 0.85 NPC1 (0.61) AOC3NPC1RAB9ATAAR1MEN1
SCHEMBL8384291 0.83 MTNR1A (0.60) AOC3NPC1RAB9ATAAR1TP53
SCHEMBL2091303 0.83 MTNR1A (0.60) AOC3NPC1RAB9ATAAR1TP53
Hydrochloric Acid SCHEMBL4323386 0.83 TAAR1 (0.60) AOC3NPC1RAB9ATAAR1MEN1
SCHEMBL8384245 0.83 MTNR1A (0.60) AOC3NPC1RAB9ATAAR1TP53
SCHEMBL3903374 0.82 BCAT2 (0.72) BCAT2NPC1RAB9AMEN1KMT2A
SCHEMBL12862954 0.81 NPC1 (0.58) AOC3NPC1RAB9ATAAR1KMT2A
SCHEMBL17198959 0.81 AOC3 (0.58) BCAT2AOC3NPC1RAB9ATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0344425-B1 N-[[(2,6-disubstituted)phenyl]-N'- arylalkyl] ureas as antihypercholesterolemic and antiatherosclerotic agents WARNER LAMBERT CO (US) 1993-12-08 — — EP claimed
EP-0344425-A2 N-[[(2,6-disubstituted)phenyl]-N'- arylalkyl] ureas as antihypercholesterolemic and antiatherosclerotic agents WARNER-LAMBERT COMPANY (US) 1989-12-06 — — EP claimed
WO-2011107443-A1 USE OF PROPINEB FOR PHYSIOLOGICAL CURATIVE TREATMENT UNDER ZINC DEFICIENCY BAYER CROPSCIENCE AG (DE) 2011-09-09 — — WO disclosed
EP-0344425-B1 N-[[(2,6-disubstituted)phenyl]-N'- arylalkyl] ureas as antihypercholesterolemic and antiatherosclerotic agents WARNER LAMBERT CO (US) 1993-12-08 — — EP disclosed
EP-0344425-A2 N-[[(2,6-disubstituted)phenyl]-N'- arylalkyl] ureas as antihypercholesterolemic and antiatherosclerotic agents WARNER-LAMBERT COMPANY (US) 1989-12-06 — — EP disclosed
Send feedback